The International Society of Chemotherapy (ISC) is a non-profit organisation (charity) registered in the UK. 2011 marks ISC’s 50th anniversary.
The ISC aims to advance the science of therapy of infection and of cancer and education on these topics through an international federation of affiliated national and regional societies with similar aims and objectives to its own. The ISC has grown to a worldwide membership of 85 national and regional societies, which in turn have more than 50,000 individual members. The Member Societies hold their own congresses, supported by the ISC.
The ISC promotes the conduct of scientific research, convening international congresses, conferences and symposia and encourages co-operation within the society and between scientists belonging to other societies dealing with related basic and clinical sciences. In the last decade, most ISC work has been on antimicrobials.
The ISC has 17 Working Groups and Sections and actively encourages and/or sponsors the formation of international working groups for special research, training projects or the use of therapeutics in the field of anti-infective and anti-neoplastic therapy. The Working Groups contribute significantly to meetings in the ISC Disease Management Series. In addition, the ISC awards scholarships and bursaries to enable attendance at and travel to its international congresses.
The Society is governed by its Trustees, Executive Committee and Council, which are led by Professor Teresita Mazzei, ISC President. The ISC Council consists of representatives of ISC Member Societies and meets at least every two years during the Society’s biannual International Congress of Chemotherapy. The Society’s official journal is the International Journal of Antimicrobial Agents and Chemotherapy (IJAA). www.ischemo.org
ReAct is an independent global network for concerted action on antibiotic resistance. ReAct aims for profound change in awareness and action to manage the interacting social, political, ecological and technical forces that drive the rising rate of resistant human and animal infections and the rapid spread of resistance within and between communities and countries.
ReAct acts as a forum for ideas, debate and collaboration between diverse stakeholders. It believes change will depend on engaging with social movements, civil society, community and consumer organizations, academia, health policy reformers and those individuals, networks or institutions that generate and analyze health-related knowledge and catalysing interaction between them on the issue.
ReAct coordinates many specific activities and concerted action planning with these groups aiming to create the environment for policy, programme and community action on antibiotic resistance at global, national and local levels.
ReAct's vision is that current and future generations of people around the globe will have access to effective prevention and treatment of bacterial infections as part of their right to health. For more information please see: www.reactgroup.org
Delegates are supported by the Wockhardt Research Centre.